Predictors of virologic and Clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine: AIDS Clinical Trials Group Protocol 320
- Author
- DEMETER, Lisa M; HUGHES, Michael D; HAMMER, Scott M; COOMBS, Robert W; JACKSON, J. Brooks; GRIMES, Janet M; BOSCH, Ronald J; FISCUS, Susan A; SPECTOR, Stephen A; SQUIRES, Kathleen E; FISCHL, Margaret A
Columbia University, New York, New York, United States
Harvard School of Public Health, Boston, Massachusetts, United States
Johns Hopkins University, Baltimore, Maryland, United States
University of Alabama at Birmingham, Birmingham, Alabama, United States
University of California, San Diego, California, United States
University of Miami School of Medicine, Miami, Florida, United States
University of North Carolina, Chapel Hill, North Carolina, United States
University of Rochester School of Medicine and Dentistry, Rochester, New York, United States
University of Washington, Seattle, Washington, United States - Source
Annals of internal medicine. 2001, Vol 135, Num 11, pp 954-964 ; ref : 20 ref
- CODEN
- AIMEAS
- ISSN
- 0003-4819
- Scientific domain
- General medicine general surgery
- Publisher
- American College of Physicians, Philadelphia, PA
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Adulte Antiviral Association médicamenteuse Chimiothérapie Didésoxynucléoside Efficacité traitement Essai clinique phase III Facteur prédictif Indinavir Lamivudine Pyrimidine nucléoside SIDA Zidovudine Nucléoside analogue Homme Immunodéficit Immunopathologie Infection Traitement Virose
- Keyword (en)
- Adult Antiviral Drug combination Chemotherapy Dideoxynucleoside Treatment efficiency Phase III trial Predictive factor Indinavir Lamivudine Pyrimidine nucleoside AIDS Zidovudine Human Immune deficiency Immunopathology Infection Treatment Viral disease
- Keyword (es)
- Adulto Antiviral Asociación medicamentosa Quimioterapia Didesoxinucleósido Eficacia tratamiento Ensayo clínico fase III Factor predictivo Indinavir Lamivudina Pirimidina nucleósido SIDA Zidovudina Hombre Inmunodeficiencia Inmunopatología Infección Tratamiento Virosis
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02S Antibiotics. Antiinfectious agents. Antiparasitic agents / 002B02S05 Antiviral agents
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B05 Infectious diseases / 002B05C Viral diseases / 002B05C02 Human viral diseases / 002B05C02D Viral diseases of the lymphoid tissue and the blood. Aids
- Discipline
- Infectious pathology Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 14115732
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.7326/0003-4819-135-11-200112040-00007 
https://dx.doi.org/10.7326/0003-4819-135-11-200112040-00007
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:40:\"10.7326\/0003-4819-135-11-200112040-00007\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:187:\"Predictors of virologic and Clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine: AIDS Clinical Trials Group Protocol 320\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Annals of internal medicine\";s:9:\"\u0000*\u0000stitle\";s:16:\"Ann. intern. med\";s:7:\"\u0000*\u0000date\";s:4:\"2001\";s:9:\"\u0000*\u0000volume\";s:3:\"135\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:3:\"954\";s:8:\"\u0000*\u0000epage\";s:3:\"964\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-4819\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"DEMETER\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Lisa M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:17:\"HUGHES, Michael D\";i:1;s:15:\"HAMMER, Scott M\";i:2;s:16:\"COOMBS, Robert W\";i:3;s:18:\"JACKSON, J. Brooks\";i:4;s:15:\"GRIMES, Janet M\";i:5;s:15:\"BOSCH, Ronald J\";i:6;s:15:\"FISCUS, Susan A\";i:7;s:18:\"SPECTOR, Stephen A\";i:8;s:19:\"SQUIRES, Kathleen E\";i:9;s:18:\"FISCHL, Margaret A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AIMEAS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:187:\"Predictors of virologic and Clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine: AIDS Clinical Trials Group Protocol 320\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:30:\"American College of Physicians\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:40:\"10.7326\/0003-4819-135-11-200112040-00007\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:187:\"Predictors of virologic and Clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine: AIDS Clinical Trials Group Protocol 320\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Annals of internal medicine\";s:9:\"\u0000*\u0000stitle\";s:16:\"Ann. intern. med\";s:7:\"\u0000*\u0000date\";s:4:\"2001\";s:9:\"\u0000*\u0000volume\";s:3:\"135\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:3:\"954\";s:8:\"\u0000*\u0000epage\";s:3:\"964\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-4819\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"DEMETER\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Lisa M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:17:\"HUGHES, Michael D\";i:1;s:15:\"HAMMER, Scott M\";i:2;s:16:\"COOMBS, Robert W\";i:3;s:18:\"JACKSON, J. Brooks\";i:4;s:15:\"GRIMES, Janet M\";i:5;s:15:\"BOSCH, Ronald J\";i:6;s:15:\"FISCUS, Susan A\";i:7;s:18:\"SPECTOR, Stephen A\";i:8;s:19:\"SQUIRES, Kathleen E\";i:9;s:18:\"FISCHL, Margaret A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AIMEAS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:187:\"Predictors of virologic and Clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine: AIDS Clinical Trials Group Protocol 320\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:30:\"American College of Physicians\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:40:\"10.7326\/0003-4819-135-11-200112040-00007\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:40:\"10.7326\/0003-4819-135-11-200112040-00007\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:187:\"Predictors of virologic and Clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine: AIDS Clinical Trials Group Protocol 320\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Annals of internal medicine\";s:9:\"\u0000*\u0000stitle\";s:16:\"Ann. intern. med\";s:7:\"\u0000*\u0000date\";s:4:\"2001\";s:9:\"\u0000*\u0000volume\";s:3:\"135\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:3:\"954\";s:8:\"\u0000*\u0000epage\";s:3:\"964\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-4819\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"DEMETER\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Lisa M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:17:\"HUGHES, Michael D\";i:1;s:15:\"HAMMER, Scott M\";i:2;s:16:\"COOMBS, Robert W\";i:3;s:18:\"JACKSON, J. Brooks\";i:4;s:15:\"GRIMES, Janet M\";i:5;s:15:\"BOSCH, Ronald J\";i:6;s:15:\"FISCUS, Susan A\";i:7;s:18:\"SPECTOR, Stephen A\";i:8;s:19:\"SQUIRES, Kathleen E\";i:9;s:18:\"FISCHL, Margaret A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AIMEAS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:187:\"Predictors of virologic and Clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine: AIDS Clinical Trials Group Protocol 320\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:30:\"American College of Physicians\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:40:\"10.7326\/0003-4819-135-11-200112040-00007\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:187:\"Predictors of virologic and Clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine: AIDS Clinical Trials Group Protocol 320\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Annals of internal medicine\";s:9:\"\u0000*\u0000stitle\";s:16:\"Ann. intern. med\";s:7:\"\u0000*\u0000date\";s:4:\"2001\";s:9:\"\u0000*\u0000volume\";s:3:\"135\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:3:\"954\";s:8:\"\u0000*\u0000epage\";s:3:\"964\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-4819\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"DEMETER\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Lisa M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:17:\"HUGHES, Michael D\";i:1;s:15:\"HAMMER, Scott M\";i:2;s:16:\"COOMBS, Robert W\";i:3;s:18:\"JACKSON, J. Brooks\";i:4;s:15:\"GRIMES, Janet M\";i:5;s:15:\"BOSCH, Ronald J\";i:6;s:15:\"FISCUS, Susan A\";i:7;s:18:\"SPECTOR, Stephen A\";i:8;s:19:\"SQUIRES, Kathleen E\";i:9;s:18:\"FISCHL, Margaret A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AIMEAS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:187:\"Predictors of virologic and Clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine: AIDS Clinical Trials Group Protocol 320\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:30:\"American College of Physicians\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:40:\"10.7326\/0003-4819-135-11-200112040-00007\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:187:\"Predictors of virologic and Clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine: AIDS Clinical Trials Group Protocol 320\";s:9:\"\u0000*\u0000jtitle\";s:27:\"Annals of internal medicine\";s:9:\"\u0000*\u0000stitle\";s:16:\"Ann. intern. med\";s:7:\"\u0000*\u0000date\";s:4:\"2001\";s:9:\"\u0000*\u0000volume\";s:3:\"135\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:3:\"954\";s:8:\"\u0000*\u0000epage\";s:3:\"964\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0003-4819\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"DEMETER\";s:10:\"\u0000*\u0000aufirst\";s:6:\"Lisa M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:10:{i:0;s:17:\"HUGHES, Michael D\";i:1;s:15:\"HAMMER, Scott M\";i:2;s:16:\"COOMBS, Robert W\";i:3;s:18:\"JACKSON, J. Brooks\";i:4;s:15:\"GRIMES, Janet M\";i:5;s:15:\"BOSCH, Ronald J\";i:6;s:15:\"FISCUS, Susan A\";i:7;s:18:\"SPECTOR, Stephen A\";i:8;s:19:\"SQUIRES, Kathleen E\";i:9;s:18:\"FISCHL, Margaret A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"AIMEAS\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:187:\"Predictors of virologic and Clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine: AIDS Clinical Trials Group Protocol 320\";s:8:\"\u0000*\u0000place\";s:16:\"Philadelphia, PA\";s:6:\"\u0000*\u0000pub\";s:30:\"American College of Physicians\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
